Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Statera BioPharma

Request full access

Harnessing immunotherapy to restore balance and defeat disease

Fort Collins, United StatesFounded 2020Biotech & Life Sciences

About Statera BioPharma

Statera Biopharma, Inc. is a biotechnology company focused on developing innovative treatments to restore immune health. The company operates in the biopharmaceutical sector, which involves creating drugs derived from biological sources to treat various diseases. Statera's primary clients include healthcare providers, hospitals, and research institutions that are involved in treating patients with immune-related conditions.

Statera Biopharma's business model revolves around the research, development, and commercialization of immunotherapy drugs. Immunotherapy is a type of treatment that uses the body's immune system to fight diseases, including cancer and viral infections. The company makes money by developing new drugs and therapies, obtaining regulatory approvals, and then selling these treatments to healthcare providers and institutions. Additionally, Statera may enter into partnerships or licensing agreements with larger pharmaceutical companies to further commercialize their products.

One of Statera's key products in development is STAT 205, which aims to treat acute and post-acute COVID-19 infections by modulating the immune system and reducing inflammation. This drug is currently in the clinical trial phase, with plans to evaluate its effectiveness and safety. Another significant product in their pipeline is STAT 401, an injectable drug designed to extend the duration of disease remission in patients with pancreatic cancer. This product is also in the clinical trial phase, with ongoing efforts to gather data and seek regulatory approval.

Statera Biopharma is actively involved in clinical trials and regulatory processes to bring these innovative treatments to market. The company aims to address high unmet medical needs, such as long-haul COVID-19 syndrome and pancreatic cancer, by providing new therapeutic options that improve patient outcomes.

Source: Dealroom company data

Statera BioPharma in the Fort Collins ecosystem

Live from Dealroom

The Statera BioPharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Statera BioPharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.